• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.16% Nasdaq Down0.13%

    Amicus Therapeutics, Inc. (FOLD)

    -NasdaqGM
    12.22 Down 0.06(0.49%) Jun 2, 4:00PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingMar 31, 2015Dec 31, 2014Sep 30, 2014Jun 30, 2014
    Total Revenue -   -   293   475  
    Cost of Revenue -   -   -   -  
    Gross Profit -   -   293   475  
    Operating Expenses
    Research Development16,113  15,605  12,049  9,978  
    Selling General and Administrative7,427  6,018  4,670  4,448  
    Non Recurring10  11  15  (81)
    Others508  364  375  396  
    Total Operating Expenses24,058  21,998  17,109  14,741  
    Operating Income or Loss (24,058) (21,998) (16,816) (14,266)
    Income from Continuing Operations
    Total Other Income/Expenses Net142  43  44  26  
    Earnings Before Interest And Taxes(23,916)(21,955)(16,772)(14,240)
    Interest Expense372  378  377  374  
    Income Before Tax(24,288)(22,333)(17,149)(14,614)
    Income Tax Expense -  (1,113) -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(24,288)(21,220)(17,149)(14,614)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (24,288) (21,220) (17,149) (14,614)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (24,288) (21,220) (17,149) (14,614)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.